REACT announces 2019 Pilot Studies awardees
REACT recently awarded funding to the following Pilot Studies projects:
“Lutein and Multiple Sclerosis Experimental Study (LuMES): A Randomized Pilot Trial” - Naiman A. Khan, PhD, RD, Assistant Professor, Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign.
“Nrf2 Activation, Mobility, and Energetics: A Pilot and Feasibility Clinical Trial of PB125 Treatment for Improving Musculoskeletal and Pain Outcomes in Osteoarthritis. “The NAME Trial” - Karyn L. Hamilton, PhD, Professor; Director-Translational Research on Aging and Chronic Disease Lab; Associate Director-Center for Healthy Aging, Colorado State University.
“Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis” - Stefanie Krick, MD, PhD, Assistant Professor, Department of Medicine/Pulmonary and Critical Care Medicine, and John Lowman, PT, PhD, Associate Professor, Health Professions/Physical Therapy, The University of Alabama at Birmingham.
“Vestibular Rehabilitation Utilizing Virtual Environments to Train Sensory Integration for Postural Control in a Functional Context” - Anat V. Lubetzky, PT, PhD, Assistant Professor, Steinhardt School of Culture Education and Human, Development / Physical Therapy, New York University.
“Investigating the Direct Effects of Fibro-adipogenic Progenitor Cells on Skeletal Muscle Regenerative Capacity and Insulin Resistance in Patients with Duchenne Muscular Dystrophy” - Lauren M. Sparks, PhD, Investigator, Translational Research Institute for Metabolism and Diabetes, AdventHealth Orlando.
The central goal of the REACT Center Pilot Studies Program is to catalyze the success of medical rehabilitation researchers and interdisciplinary teams by providing consultation, seed funds, key expertise and resources for the conduct of innovative pilot projects, early-stage proof-of-concept studies, and futility studies needed to shape more definitive clinical trials.
Learn about all prior REACT Pilot Studies awardees.
Posted: June 26, 2019